Cleared Traditional

K142693 - ZywieAI Software Library

K142693 is an FDA 510(k) clearance for ZywieAI Software Library, manufactured by Zywie, Inc.. The device is a Class 2 Cardiovascular device with product code DPS cleared through the Traditional 510(k) pathway after a 151-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2015
Decision
151d
Days
Class 2
Risk

K142693 is an FDA 510(k) clearance for the ZywieAI Software Library. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Zywie, Inc. (Johns Creek, US). The FDA issued a Cleared decision on February 20, 2015 after a review of 151 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Zywie, Inc. devices

FDA 510(k) Submission Details - K142693

510(k) Number K142693 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 22, 2014
Decision Date February 20, 2015
Days to Decision 151 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
26d slower than avg
Panel avg: 125d · This submission: 151d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPS Device Classification - Class 2, Special Controls

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 283
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K142693.
PC ECG
K161302 · Edan Instruments, Inc. · Jul 2016
PC ECG
K152427 · Edan Instruments, Inc. · Feb 2016
Xscribe Stress Exercise Testing Systems, Q-Stress Stress Exercise Testing Systems
K152944 · Mortara Instrument, Inc. · Jan 2016
ELI 380 ELECTROCARDIOGRAPH
K142105 · Mortara Instrument, Inc. · Sep 2014
SE-601 SERIES ELECTROCARDIOGRAPH
K131503 · Edan Instruments, Inc. · Feb 2014
PC ECG
K131819 · Edan Instruments, Inc. · Nov 2013